{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:53:34Z","timestamp":1791204814147,"version":"4.1.0"},"reference-count":65,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVE<\/jats:title>\n                    <jats:p>Urinary tract infection (UTI) is a common bacterial infection during childhood. This article reports on a technical review investigating the management of UTI to inform the development of an updated clinical practice guideline (CPG) by the American Academy of Pediatrics (AAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors performed 5 systematic reviews comparing different options for: 1) antibiotic duration in children without known anatomic anomalies; 2) antibiotic route in children without known anatomic anomalies; 3) use of continuous antibiotic prophylaxis (CAP) for children with vesicoureteral reflux (VUR); 4) use of CAP for children with bowel and bladder dysfunction (BBD); and 5) timing of evaluation of children with suspected UTI. We performed database searches of Medline via PubMed, Embase, and Cochrane library from January 1, 2008, through August 5, 2023. Eligible studies were published in English and compared management strategies in a population of children with UTI, suspected UTI, acute pyelonephritis, VUR, and\/or BBD. Data on study characteristics and patient-important outcomes were extracted from studies and pooled using meta-analysis when appropriate. Risk of bias was assessed using the Prediction model of Risk Of Bias ASsessment Tool, the Risk of Bias in Nonrandomized Studies of Interventions, and version 2 of the Cochrane risk-of-bias tool for randomized trials. Certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Out of 6154 identified records, a total of 60 studies were included. Overall, there was low to very low certainty regarding the effects of any intervention on patient outcomes. These results suggest that a relatively shorter course of antibiotic therapy (7\u00a0days or fewer) may not increase the risk of recurrent UTI, although it is likely to reduce the adverse events associated with antibiotic therapy. Additionally, oral antibiotic therapy may be similarly effective to parenteral (or parenteral-to-oral) therapy while avoiding potential harms associated with hospitalization. Rates of breakthrough UTI and renal scarring may be similar among children who receive CAP compared with those who do not, but rates of antibiotic-resistant UTI may increase with administration of CAP. Prompt medical evaluation within 72 hours of symptom onset may be associated with less renal scarring compared with later evaluation and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>These results informed the development of the updated AAP CPG on the management of pediatric UTI, including recommendations on the duration of antibiotic therapy, route of antibiotic administration, use of prophylaxis in children with VUR and BBD, and timing of medical evaluation when UTI is suspected. Specific areas of uncertainty identified through this review may be addressed with future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2026-078568","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:02:38Z","timestamp":1790553758000},"source":"Crossref","is-referenced-by-count":2,"title":["A Systematic Review and Meta-Analysis of the Prevention and Management of Pediatric Urinary Tract Infection and Suspected Urinary Tract Infection: Technical Report"],"prefix":"10.1542","volume":"158","author":[{"given":"Leena","family":"AlShenaiber","sequence":"first","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"},{"name":"2College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Senerth","sequence":"additional","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoluwa","family":"Babatunde","sequence":"additional","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"},{"name":"3Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volf","family":"Gaby","sequence":"additional","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Nazzal","sequence":"additional","affiliation":[{"name":"4Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Pilcher","sequence":"additional","affiliation":[{"name":"5Department of Child Health Finance and Quality, American Academy of Pediatrics, Itasca, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Tangri","sequence":"additional","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Sofi-Mahmudi","sequence":"additional","affiliation":[{"name":"6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Schroeder","sequence":"additional","affiliation":[{"name":"7Division of Pediatric Hospital Medicine, Stanford Medicine Children\u2019s Health, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"},{"name":"4Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, Kansas"},{"name":"6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"8Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Morgan","sequence":"additional","affiliation":[{"name":"1Evidence Foundation, Cleveland, Ohio"},{"name":"3Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio"},{"name":"6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"1","key":"2026100508173486100_r1","doi-asserted-by":"crossref","first-page":"e000487","DOI":"10.1136\/bmjpo-2019-000487","article-title":"Urinary tract infections in children: an overview of diagnosis and management","volume":"3","author":"Kaufman","year":"2019","journal-title":"BMJ Paediatr Open."},{"issue":"3","key":"2026100508173486100_r2","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1542\/peds.2011-1332","article-title":"Technical report\u2014Diagnosis and management of an initial UTI in febrile infants and young children","volume":"128","author":"Finnell","year":"2011","journal-title":"Pediatrics."},{"issue":"1","key":"2026100508173486100_r3","first-page":"CD003966","article-title":"Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children","author":"Michael","year":"2003","journal-title":"Cochrane Database Syst Rev."},{"issue":"7","key":"2026100508173486100_r4","first-page":"CD003772","article-title":"Antibiotics for acute pyelonephritis in children","volume":"2014","author":"Strohmeier","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"2026100508173486100_r5","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1542\/peds.103.4.e54","article-title":"Technical report: urinary tract infections in febrile infants and young children","volume":"103","author":"Downs","year":"1999","journal-title":"Pediatrics."},{"issue":"8","key":"2026100508173486100_r6","first-page":"1815","article-title":"The AAP practice parameter on urinary tract infections in febrile infants and young children","volume":"62","author":"Roberts","year":"2000","journal-title":"Am Fam Physician."},{"issue":"3","key":"2026100508173486100_r7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months","volume":"128","author":"Roberts","year":"2011","journal-title":"Pediatrics."},{"issue":"6","key":"2026100508173486100_r8","doi-asserted-by":"crossref","first-page":"e20163026","DOI":"10.1542\/peds.2016-3026","article-title":"Reaffirmation of AAP Clinical Practice Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children 2\u201324 Months of Age","volume":"138","author":"Roberts","year":"2016","journal-title":"Pediatrics."},{"issue":"4","key":"2026100508173486100_r9","doi-asserted-by":"crossref","first-page":"e2026078565","DOI":"10.1542\/peds.2026-078565","article-title":"Clinical practice guideline for the diagnosis and treatment of urinary tract infection in children from 8 days to 5 years of age","volume":"158","author":"Alverson","year":"2026","journal-title":"Pediatrics."},{"issue":"71","key":"2026100508173486100_r10","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"2026100508173486100_r11","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"2026100508173486100_r12","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ."},{"issue":"1","key":"2026100508173486100_r13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med."},{"issue":"Pt A","key":"2026100508173486100_r14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"2026100508173486100_r15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol."},{"key":"2026100508173486100_r16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinepi.2019.12.023","article-title":"GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks","volume":"121","author":"Foroutan","year":"2020","journal-title":"J Clin Epidemiol."},{"issue":"12","key":"2026100508173486100_r17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"2","key":"2026100508173486100_r18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol."},{"key":"2026100508173486100_r19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"J Clin Epidemiol."},{"issue":"2","key":"2026100508173486100_r20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00365549109023403","article-title":"Short-term treatment of acute urinary tract infection in girls","volume":"23","author":"Petersen","year":"1991","journal-title":"Scand J Infect Dis."},{"issue":"5","key":"2026100508173486100_r21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01640727","article-title":"Short-term treatment of lower urinary tract infections in children with trimethoprim\/sulphadiazine","volume":"9","author":"Helin","year":"1981","journal-title":"Infection."},{"issue":"10","key":"2026100508173486100_r22","first-page":"1090","article-title":"The role of bacterial adhesins in the outcome of childhood urinary tract infections","volume":"147","author":"Johnson","year":"1993","journal-title":"AJDC 1960"},{"issue":"2","key":"2026100508173486100_r23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02549709","article-title":"Comparison of 3-day versus 14-day treatment of lower urinary tract infection in children","volume":"23","author":"J\u00f3j\u00e1rt","year":"1991","journal-title":"Int Urol Nephrol."},{"issue":"6","key":"2026100508173486100_r24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-3476(81)80037-6","article-title":"Three-day therapy of lower urinary tract infections with nitrofurantoin macrocrystals: a randomized clinical trial","volume":"99","author":"Lohr","year":"1981","journal-title":"J Pediatr."},{"issue":"5","key":"2026100508173486100_r25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00006454-198805000-00004","article-title":"Single dose antibiotic therapy is not as effective as conventional regimens for management of acute urinary tract infections in children","volume":"7","author":"Madrigal","year":"1988","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"2026100508173486100_r26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02724936.1986.11748440","article-title":"Nalidixic acid and trimethoprim\/sulphamethoxazole as alternatives for short-term treatment of urinary infections","volume":"6","author":"Zaki","year":"1986","journal-title":"Ann Trop Paediatr."},{"issue":"8","key":"2026100508173486100_r27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jamapediatrics.2023.1979","article-title":"Short-Course Therapy for Urinary Tract Infections in Children: The SCOUT Randomized Clinical Trial","volume":"177","author":"Zaoutis","year":"2023","journal-title":"JAMA Pediatr."},{"issue":"3","key":"2026100508173486100_r28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000168709","article-title":"Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children","volume":"14","author":"Kornberg","year":"1994","journal-title":"Am J Nephrol."},{"issue":"9","key":"2026100508173486100_r29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1651-2227.1992.tb12336.x","article-title":"Single daily doses of trimethoprim\/sulphadiazine for three or 10 days in urinary tract infections","volume":"81","author":"Gaudreault","year":"1992","journal-title":"Acta Paediatr Oslo Nor."},{"issue":"5","key":"2026100508173486100_r30","doi-asserted-by":"crossref","first-page":"e203951","DOI":"10.1001\/jamanetworkopen.2020.3951","article-title":"Comparative Effectiveness of Antibiotic Treatment Duration in Children With Pyelonephritis","volume":"3","author":"Fox","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"1","key":"2026100508173486100_r31","doi-asserted-by":"crossref","first-page":"e2023062598","DOI":"10.1542\/peds.2023-062598","article-title":"Short Oral Antibiotic Therapy for Pediatric Febrile Urinary Tract Infections: A Randomized Trial","volume":"153","author":"Montini","year":"2024","journal-title":"Pediatrics."},{"issue":"2","key":"2026100508173486100_r32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpedi.155.2.135","article-title":"The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections","volume":"155","author":"Baker","year":"2001","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"1 Pt 1","key":"2026100508173486100_r33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.104.1.79","article-title":"Oral versus initial intravenous therapy for urinary tract infections in young febrile children","volume":"104","author":"Hoberman","year":"1999","journal-title":"Pediatrics."},{"issue":"7616","key":"2026100508173486100_r34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bmj.39244.692442.55","article-title":"Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial","volume":"335","author":"Montini","year":"2007","journal-title":"BMJ."},{"issue":"9","key":"2026100508173486100_r35","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00431-007-0638-1","article-title":"Randomised trial of oral versus sequential intravenous\/oral cephalosporins in children with pyelonephritis","volume":"167","author":"Neuhaus","year":"2008","journal-title":"Eur J Pediatr."},{"issue":"10","key":"2026100508173486100_r36","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/archdischild-2021-323554","article-title":"Short-course intravenous antibiotics for young infants with urinary tract infection","volume":"107","author":"Lawrence","year":"2022","journal-title":"Arch Dis Child."},{"issue":"1","key":"2026100508173486100_r37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/pch\/pxz164","article-title":"Transition to oral antibiotic therapy for pyelonephritis in children under 60 days of age: An observational retrospective cohort study","volume":"26","author":"Lessard","year":"2020","journal-title":"Paediatr Child Health."},{"issue":"7","key":"2026100508173486100_r38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1542\/hpeds.2021-006479","article-title":"Impact of Early Oral Antibiotic Therapy in Infants With Bacteremic Urinary Tract Infections","volume":"12","author":"Olson","year":"2022","journal-title":"Hosp Pediatr."},{"issue":"3","key":"2026100508173486100_r39","doi-asserted-by":"crossref","first-page":"e20183844","DOI":"10.1542\/peds.2018-3844","article-title":"Parenteral Antibiotic Therapy Duration in Young Infants With Bacteremic Urinary Tract Infections","volume":"144","author":"Desai","year":"2019","journal-title":"Pediatrics."},{"issue":"3","key":"2026100508173486100_r40","doi-asserted-by":"crossref","first-page":"e20180900","DOI":"10.1542\/peds.2018-0900","article-title":"Emergency Department Revisits After an Initial Parenteral Antibiotic Dose for UTI","volume":"142","author":"Chaudhari","year":"2018","journal-title":"Pediatrics."},{"issue":"2","key":"2026100508173486100_r41","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1542\/peds.2011-0814","article-title":"Randomized trial of oral versus sequential IV\/oral antibiotic for acute pyelonephritis in children","volume":"129","author":"Bocquet","year":"2012","journal-title":"Pediatrics."},{"issue":"10","key":"2026100508173486100_r42","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1177\/00099228231154364","article-title":"A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants &lt;60 Days of Age","volume":"62","author":"Zu\u2019bi","year":"2023","journal-title":"Clin Pediatr (Phila)."},{"issue":"2","key":"2026100508173486100_r43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1542\/peds.2009-2948","article-title":"Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections","volume":"126","author":"Brady","year":"2010","journal-title":"Pediatrics."},{"issue":"18","key":"2026100508173486100_r44","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa0902295","article-title":"Antibiotic prophylaxis and recurrent urinary tract infection in children","volume":"361","author":"Craig","year":"2009","journal-title":"N Engl J Med."},{"issue":"3","key":"2026100508173486100_r45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00467-014-2943-z","article-title":"Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double-blind placebo-controlled trial","volume":"30","author":"Hari","year":"2015","journal-title":"Pediatr Nephrol."},{"issue":"25","key":"2026100508173486100_r46","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMoa1401811","article-title":"Antimicrobial prophylaxis for children with vesicoureteral reflux","volume":"370","author":"Hoberman","year":"2014","journal-title":"N Engl J Med."},{"issue":"6","key":"2026100508173486100_r47","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1542\/peds.2007-2652","article-title":"Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial","volume":"121","author":"Pennesi","year":"2008","journal-title":"Pediatrics."},{"issue":"11","key":"2026100508173486100_r48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa2300161","article-title":"Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux","volume":"389","author":"Morello","year":"2023","journal-title":"N Engl J Med."},{"issue":"1","key":"2026100508173486100_r49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.juro.2010.01.061","article-title":"The Swedish reflux trial in children: III. Urinary tract infection pattern","volume":"184","author":"Brandstr\u00f6m","year":"2010","journal-title":"J Urol."},{"issue":"1","key":"2026100508173486100_r50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.juro.2010.01.059","article-title":"The Swedish reflux trial in children: II. Vesicoureteral reflux outcome","volume":"184","author":"Holmdahl","year":"2010","journal-title":"J Urol."},{"issue":"5","key":"2026100508173486100_r51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1542\/peds.2007-3770","article-title":"Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial","volume":"122","author":"Montini","year":"2008","journal-title":"Pediatrics."},{"issue":"3","key":"2026100508173486100_r52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1542\/peds.2005-1362","article-title":"Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study","volume":"117","author":"Garin","year":"2006","journal-title":"Pediatrics."},{"issue":"4","key":"2026100508173486100_r53","doi-asserted-by":"crossref","first-page":"e20152490","DOI":"10.1542\/peds.2015-2490","article-title":"Antimicrobial Resistance and Urinary Tract Infection Recurrence","volume":"137","author":"Nelson","year":"2016","journal-title":"Pediatrics."},{"issue":"2","key":"2026100508173486100_r54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jamapediatrics.2016.3349","article-title":"Weight Gain and Obesity in Infants and Young Children Exposed to Prolonged Antibiotic Prophylaxis","volume":"171","author":"Edmonson","year":"2017","journal-title":"JAMA Pediatr."},{"issue":"1","key":"2026100508173486100_r55","doi-asserted-by":"crossref","first-page":"e20152982","DOI":"10.1542\/peds.2015-2982","article-title":"Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction","volume":"137","author":"Shaikh","year":"2016","journal-title":"Pediatrics."},{"issue":"1","key":"2026100508173486100_r56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/tp-21-398","article-title":"Risk factors for breakthrough urinary tract infection in children with vesicoureteral reflux receiving continuous antibiotic prophylaxis","volume":"11","author":"Su","year":"2022","journal-title":"Transl Pediatr."},{"issue":"2","key":"2026100508173486100_r57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/JU.0000000000000292","article-title":"Why Does Prevention of Recurrent Urinary Tract Infection not Result in Less Renal Scarring? A Deeper Dive into the RIVUR Trial","volume":"202","author":"Wang","year":"2019","journal-title":"J Urol."},{"issue":"3","key":"2026100508173486100_r58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1542\/peds.2007-2894","article-title":"Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials","volume":"122","author":"Hewitt","year":"2008","journal-title":"Pediatrics."},{"issue":"1","key":"2026100508173486100_r59","first-page":"149","article-title":"Delayed treatment of the first febrile urinary tract infection in early childhood increased the risk of renal scarring","volume":"106","author":"Karavanaki","year":"2017","journal-title":"Acta Paediatr Oslo Nor 1992"},{"issue":"9","key":"2026100508173486100_r60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamapediatrics.2016.1181","article-title":"Early Antibiotic Treatment for Pediatric Febrile Urinary Tract Infection and Renal Scarring","volume":"170","author":"Shaikh","year":"2016","journal-title":"JAMA Pediatr."},{"issue":"4","key":"2026100508173486100_r61","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1542\/peds.2006-2417","article-title":"Does early treatment of urinary tract infection prevent renal damage?","volume":"120","author":"Doganis","year":"2007","journal-title":"Pediatrics."},{"issue":"3","key":"2026100508173486100_r62","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1542\/peds.2006-3632","article-title":"Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months","volume":"121","author":"Bouissou","year":"2008","journal-title":"Pediatrics."},{"issue":"4","key":"2026100508173486100_r63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/archdischild-2013-304428","article-title":"Does prompt treatment of urinary tract infection in preschool children prevent renal scarring: mixed retrospective and prospective audits","volume":"99","author":"Coulthard","year":"2014","journal-title":"Arch Dis Child."},{"issue":"3","key":"2026100508173486100_r64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/adc.84.3.241","article-title":"Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring","volume":"84","author":"Benador","year":"2001","journal-title":"Arch Dis Child."},{"issue":"1","key":"2026100508173486100_r65","first-page":"21","article-title":"Risk factors in the development of early technetium-99m dimercaptosuccinic acid renal scintigraphy lesions during first urinary tract infection in children","volume":"92","author":"Fern\u00e1ndez-Men\u00e9ndez","year":"2003","journal-title":"Acta Paediatr Oslo Nor 1992"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2026-078568\/1971236\/pediatrics.2026078568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2026-078568\/1971236\/pediatrics.2026078568.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:17:43Z","timestamp":1791202663000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/158\/4\/e2026078568\/209456\/A-Systematic-Review-and-Meta-Analysis-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,9,28]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2026-078568","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"e2026078568"}}